Related Experiment Video
Updated: Apr 29, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Subclinical celiac disease and gluten sensitivity
Mohammad Rostami Nejad1, Sabine Hogg-Kollars2, Sauid Ishaq3
1Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Atypical celiac disease (CD) presentations are common. Simplifying terminology and applying gluten-free diets (GFD) to all CD forms, including atypical ones, can improve patient care.
Area of Science:
- Gastroenterology
- Immunology
- Clinical Medicine
Background:
- Atypical presentations are the most frequent form of celiac disease (CD).
- Existing terminologies like latent, silent, and potential CD contribute to clinical confusion due to varied definitions.
- Advances in understanding non-celiac gluten sensitivity necessitate clearer CD classification.
Purpose of the Study:
- To propose simplified terminology for atypical celiac disease.
- To advocate for a consistent gluten-free diet (GFD) approach across all CD manifestations.
- To reduce diagnostic and therapeutic uncertainty for clinicians and patients.
Main Methods:
- Review of current literature on celiac disease and non-celiac gluten sensitivity.
- Analysis of clinical and pathological behaviors associated with different CD presentations.
- Comparative assessment of diagnostic and therapeutic strategies.
Main Results:
- The terms 'subclinical' and 'atypical' may offer clearer distinctions than 'silent' and 'potential/latent' CD.
- Evidence supports a lower threshold for initiating a GFD in non-celiac gluten sensitivity.
- A unified GFD strategy is beneficial for all forms of CD.
Conclusions:
- Adopting simplified terminology ('subclinical' and 'atypical') can enhance understanding of celiac disease.
- A gluten-free diet (GFD) is recommended for all recognized forms of celiac disease.
- Standardized terminology and treatment protocols are crucial for optimal celiac disease management.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Other Disorders of Digestive System
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

